Stay updated on Nivolumab for Uterine Cancer - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s displayed release/version identifier was updated from “v3.5.2” to “v3.5.3,” reflecting a change in the ClinicalTrials.gov site build rather than the underlying study details.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No other content changes are indicated.SummaryDifference0.1%

- Check56 days agoChange DetectedPage revision tag updated to v3.5.0, replacing the previous v3.4.3. This appears to be a minor maintenance update unrelated to study data or usability.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page's revision label has been updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded Revision: v3.4.2. Removed earlier notices including Revision: v3.4.1 and the government funding status notice with links to operating status.SummaryDifference0.4%

- Check98 days agoChange DetectedNotice about government funding lapse and NIH Clinical Center operating status added; revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.